Skip to main content
Oxford University Hospitals NHS Foundation Trust
Children's Haematology and Oncology

This site is best viewed with a modern browser. You appear to be using an old version of Internet Explorer.

Haemophilia Service

Oxford Haemophilia and Thrombosis Centre (OHTC) is a large comprehensive centre providing care to patients with inherited and acquired bleeding and clotting disorders.

This service includes the Adult Haemophilia Service, which is based at the Churchill Hospital.

Our team of consultants, registrars, nurses and physiotherapists are trained in haemostasis and thrombosis disorders.

For more details about the team, please see Our team

We provide a range of services for both inpatients and outpatients at Oxford Children's Hospital.

Our services include:

  • emergency treatment of bleeds
  • regular assessments, reviews and screening
  • physiotherapy
  • investigation of patients with bleeding and thrombotic disorders
  • education for patients and carers
  • psychology
  • information and advice for health care professionals, employers and schools
  • participation in clinical research.

Contact us

Our clinic is based in Lion Room, Children's Outpatients, Level LG1 Oxford Children's Hospital.

Patient leaflets

Please see our online Patient leaflets for the following leaflets for haemophilia patients:

  • Insertion of a Hickman Line
  • Insertion of a port-a-cath
  • Tranexamic acid


Oxford Haemophilia and Thrombosis Centre is very active in clinical research, participating in many national and international studies.

If you have haemophilia, or other rare conditions, you are very likely to be asked to consider taking part in a study to help improve future treatment.

This could range from answering a few questions and/or a single blood test, through to trialling a new treatment over a number of years.

The choice to take part in research is entirely yours. If you prefer not to take part, your decision will be respected by your team and it will not affect the care you receive.

Research areas include:

  • novel non-factor haemophilia treatment
  • long-acting factor treatments
  • genetics of rare bleeding conditions
  • use of novel oral anticoagulants.